• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Higher Following PCE Inflation Data; Nasdaq Jumps Over 200 Points

    4/26/24 9:54:12 AM ET
    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Machinery/Components
    Industrials
    Get the next $BDRX alert in real time by email

    U.S. stocks traded higher this morning, with the Nasdaq Composite gaining by more than 200 points on Friday.

    Following the market opening Friday, the Dow traded up 0.20% to 38,162.13 while the NASDAQ rose 1.36% to 15,823.47. The S&P 500 also fell, dropping, 0.73% to 5,085.46.

    Check This Out: Top 4 Materials Stocks That May Explode In Q2

    Leading and Lagging Sectors

    Communication services shares rose by 4.9% on Friday.

    In trading on Friday, energy shares dipped by 1.2%.

    Top Headline

    The Federal Reserve's preferred measure of inflation – the Personal Consumption Expenditure (PCE) price index – rose more than expected in March. The headline PCE price index rose from 2.5% in February 2024 to 2.7% year-on-year in March, beating forecasts of a 2.6% increase, the Bureau of Economic Analysis reported Friday.

    Equities Trading UP
                          

    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) shares shot up 86% to $1.33 after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.
    • Shares of Focus Universal Inc. (NASDAQ:FCUV) got a boost, surging 69% to $0.4787 after the company announced board approval for the spin-off of Lusher.
    • Pineapple Energy Inc. (NASDAQ:PEGY) shares were also up, gaining 68% to $0.0871.

    Equities Trading DOWN

    • iClick Interactive Asia Group Limited (NASDAQ:ICLK) shares dropped 50% to $1.27 after the company announced the termination of its merger agreement.
    • Shares of Nuwellis, Inc. (NASDAQ:NUWE) were down 43% to $0.1650 after the company reported pricing of $2.7 million public offering.
    • Nature Wood Group Limited (NASDAQ:NWGL) was down, falling 39% to $10.31.

    Also Check This Out: How To Earn $500 A Month From Domino’s Pizza Stock Ahead Of Q1 Earnings

    Commodities

    In commodity news, oil traded up 0.7% to $84.12 while gold traded up 0.7% at $2,359.00.

    Silver traded up 0.9% to $27.59 on Friday, while copper rose 1.2% to $4.5945.

    Euro zone

    European shares were higher today. The eurozone's STOXX 600 rose 0.8%, London's FTSE 100 rose 0.5% while Spain's IBEX 35 Index rose 1.4% The German DAX rose 0.8% French CAC 40 rose 0.4% while Italy's FTSE MIB Index climbed 1%.

    Bank lending to households in the Eurozone rose by 0.2% year-over-year to €6.875 trillion in March. Spain’s retail trade increased by 0.6% year-over-year in March versus a revised 1.8% gain in the earlier month, while unemployment rate increased to 12.29% in the first quarter.

    The consumer confidence indicator in France declined to 90 in April versus a reading of 91 in the prior month.

    Asia Pacific Markets

    Asian markets closed mostly higher on Friday, with Japan's Nikkei 225 gaining 0.81%, Hong Kong's Hang Seng Index jumping 2.12%, China's Shanghai Composite climbing 1.17% and India's S&P BSE Sensex falling 0.82%.

    The Bank of Japan maintained its key short-term interest rate unchanged at its April meeting. Singapore’s manufacturing production declined 9.2% year-over-year in March versus a revised 4.4% increase in the prior month.

    Economics

    The Federal Reserve's preferred measure of inflation – the Personal Consumption Expenditure (PCE) price index – rose more than expected in March. The headline PCE price index rose from 2.5% in February 2024 to 2.7% year-on-year in March, beating forecasts of a 2.6% increase, the Bureau of Economic Analysis reported Friday.

    Now Read This: ‘I Don’t Want You To Lose Any Money’: Jim Cramer On This Industrial Stock: ‘Go Buy GE Vernova’

    Get the next $BDRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BDRX
    $FCUV
    $ICLK
    $NUWE

    CompanyDatePrice TargetRatingAnalyst
    Nuwellis Inc.
    $NUWE
    7/29/2024$17.00Buy
    ROTH MKM
    Biodexa Pharmaceuticals plc American Depositary Shs
    $BDRX
    2/8/2024$8.00Buy
    Ladenburg Thalmann
    iClick Interactive Asia Group Limited
    $ICLK
    3/24/2022Buy → Neutral
    Alliance Global Partners
    More analyst ratings

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    SEC Filings

    View All

    SEC Form EFFECT filed by Nuwellis Inc.

    EFFECT - Nuwellis, Inc. (0001506492) (Filer)

    2/10/26 12:15:32 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 424B3 filed by Nuwellis Inc.

    424B3 - Nuwellis, Inc. (0001506492) (Filer)

    2/9/26 5:22:12 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Focus Universal Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - FOCUS UNIVERSAL INC. (0001590418) (Filer)

    2/5/26 9:30:23 AM ET
    $FCUV
    Industrial Machinery/Components
    Industrials

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    ROTH MKM initiated coverage on Nuwellis with a new price target

    ROTH MKM initiated coverage of Nuwellis with a rating of Buy and set a new price target of $17.00

    7/29/24 7:42:07 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Ladenburg Thalmann initiated coverage on Biodexa Pharmaceuticals PLC with a new price target

    Ladenburg Thalmann initiated coverage of Biodexa Pharmaceuticals PLC with a rating of Buy and set a new price target of $8.00

    2/8/24 7:21:49 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    iClick Interactive Asia Group downgraded by Alliance Global Partners

    Alliance Global Partners downgraded iClick Interactive Asia Group from Buy to Neutral

    3/24/22 12:13:16 PM ET
    $ICLK
    Computer Software: Prepackaged Software
    Technology

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Schultz Carisa

    3 - Nuwellis, Inc. (0001506492) (Issuer)

    2/12/26 4:15:30 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by new insider Field Katharyn

    3 - Nuwellis, Inc. (0001506492) (Issuer)

    2/11/26 3:35:38 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by new insider Grasso Mika

    3 - Nuwellis, Inc. (0001506492) (Issuer)

    2/11/26 3:31:30 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST

    February 4, 2026 Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST Novel Mechanism of Action Shown to be Effective in TKI Resistant PDX Models Cardiff, UK – February 4, 2026 – Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of rare diseases with unmet medical needs, today announced the closing of an exclusive license with Otsuka Pharmaceutical Co., Ltd (Otsuka) for OPB-171775. a novel molecular glue intended to be developed for the treatment of gastrointestinal stromal tumours (GIST). The compound also has the potential to be useful

    2/4/26 8:30:00 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nuwellis Appoints Carisa Schultz as Chief Financial Officer

    MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at NeueHealth (formerly Bright Health Group), a healthcare company previously listed on the New York Stock Exchange. In that role, she led enterprise finance, treasury, and corporate development activities. During her tenure at NeueHealth, she also held progressive leadership roles including A

    1/30/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

    MINNEAPOLIS, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) ("Nuwellis" or the "Company"), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced that it has entered into a securities purchase agreement with an institutional and accredited investor (the "Investor") for the purchase and sale of 994,537 shares (the "Shares") of the Company's common stock, $0.0001 par value (the "Common Stock") or (pre-funded warrants in-lieu thereof) together with warrants (the "Private Placement Warrants") to purchase 1,989,074 shares of Common Stock in a private placement priced at-the-market under Nasdaq rules (the "Private P

    1/29/26 4:36:12 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and Director Wang Desheng bought $2,280 worth of shares (1,000 units at $2.28) and bought $22,260 worth of shares (10,000 units at $2.23), increasing direct ownership by 0.49% to 2,273,800 units (SEC Form 4)

    4 - FOCUS UNIVERSAL INC. (0001590418) (Issuer)

    8/15/25 6:55:39 PM ET
    $FCUV
    Industrial Machinery/Components
    Industrials

    Large owner Conroy Jeffrey J. bought $40,331 worth of shares (350,704 units at $0.11) and sold $1,810 worth of shares (16,014 units at $0.11), increasing direct ownership by 18% to 2,194,690 units (SEC Form 4)

    4 - Pineapple Energy Inc. (0000022701) (Issuer)

    10/15/24 9:50:04 PM ET
    $PEGY
    Telecommunications Equipment
    Utilities

    Large owner Conroy Jeffrey J. bought $36,063 worth of shares (333,921 units at $0.11) and sold $3,133 worth of shares (29,010 units at $0.11), increasing direct ownership by 20% to 1,860,000 units (SEC Form 4)

    4 - Pineapple Energy Inc. (0000022701) (Issuer)

    10/11/24 9:52:05 PM ET
    $PEGY
    Telecommunications Equipment
    Utilities

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Leadership Updates

    Live Leadership Updates

    View All

    Nuwellis Appoints Carisa Schultz as Chief Financial Officer

    MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at NeueHealth (formerly Bright Health Group), a healthcare company previously listed on the New York Stock Exchange. In that role, she led enterprise finance, treasury, and corporate development activities. During her tenure at NeueHealth, she also held progressive leadership roles including A

    1/30/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis Announces Changes to Board of Directors

    MINNEAPOLIS, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced the appointment of Katharyn Field and Mika Grasso to its board of directors, effective January 21, 2026. Ms. Field is the Chief Executive Officer of ISpecimen Inc., where she oversees performance improvement and the redevelopment of the proprietary software platform. Prior to serving as Chief Executive Officer she served as President, Chairman, and as an independent director. She has served as a director of LogProstyle since September 2024, as an Executive Director of Akanda Corporation since Ju

    1/23/26 4:40:27 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary

    January 05, 2026 Biodexa Pharmaceuticals PLC Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, is delighted to announce the promotion of Fiona Sharp to Chief Financial Officer and Company Secretary along with her election to the Board of Directors of the Company with immediate effect. Ms Sharp is a senior finance professional having joined the Company as Group Financial Controller in December 2019. During her tenure, she has consistentl

    1/5/26 8:30:00 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Financials

    Live finance-specific insights

    View All

    Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

    MINNEAPOLIS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, addressing the critical interplay between the heart and kidneys, today announced that it will release financial results for the third quarter 2025 on November 12, 2025. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update. To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing 1-800-274-8461 (U.S) or 1-203-51

    10/23/25 9:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

    MINNEAPOLIS, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company focused on fluid management, today announced that it will postpone its 2025 second quarter earnings release and conference call, originally scheduled for August 12, 2025. The Company requires additional time to complete its valuations and for its audit firm to complete its related audit procedures. There are no current disagreements with Baker Tilly US, LLP, the Company's auditor. The Company expects to host a conference call and webcast at 9:00 AM ET on August 14, 2025 to discuss its financial results and provide a general business update. To access the live webcast, please visit the

    8/6/25 8:15:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

    MINNEAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the second quarter 2025 on August 12, 2025. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update. To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing 1-800-245-3047 (U.S) or 1-203-518-9765 (international) and using the conference ID: NUWEQ2. A

    7/22/25 8:15:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by iClick Interactive Asia Group Limited

    SC 13D/A - iClick Interactive Asia Group Ltd (0001697818) (Subject)

    12/11/24 7:11:44 AM ET
    $ICLK
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Biodexa Pharmaceuticals plc American Depositary Shs

    SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)

    11/20/24 11:56:39 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Biodexa Pharmaceuticals plc American Depositary Shs

    SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)

    11/14/24 5:12:47 PM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care